Ikarian Capital’s Connect Biopharma Holdings CNTB Stock Holding History

Ikarian Capital’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1M	Buy	5,388,486 +600,000	+13%	+$1.56M	1.07%	23
2025 Q4	$13.5M	Buy	+4,788,486	New	+$10.2M	1.05%	29
2023 Q3	–	Sell	-219,501	Closed	-$244K	–	156
2023 Q2	$244K	Hold	219,501	–	–	0.04%	109
2023 Q1	$219K	Hold	219,501	–	–	0.05%	105
2022 Q4	$190K	Hold	219,501	–	–	0.05%	73
2022 Q3	$283K	Sell	219,501 -458,358	-68%	-$551K	0.06%	91
2022 Q2	$591K	Hold	677,859	–	–	0.11%	100
2022 Q1	$2.05M	Buy	677,859 +415,622	+158%	+$1.75M	0.27%	69
2021 Q4	$1.35M	Buy	+262,237	New	+$2.91M	0.2%	84

Other funds holding CNTB

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ikarian Capital's CNTB Position: Q1 2026 in Review

Ikarian Capital increased its Connect Biopharma Holdings (CNTB) stake by 13% in Q1 2026, buying an estimated $1.56M and bringing the position to 5,388,486 shares worth $13.1M. The position accounts for 1.07% of the portfolio, ranked #23.

Ikarian Capital first reported a position in CNTB in Q4 2021 and has held it in 9 quarters since. The position peaked at $13.5M in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

Ikarian Capital held 5,388,486 shares of Connect Biopharma Holdings worth $13.1M as of Q1 2026.
Ikarian Capital bought 600,000 Connect Biopharma Holdings shares in Q1 2026, an estimated $1.56M.
Connect Biopharma Holdings made up 1.07% of Ikarian Capital's portfolio in Q1 2026, its #23 holding.
Ikarian Capital first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 9 quarters since.
Ikarian Capital's Connect Biopharma Holdings position peaked at $13.5M in Q4 2025.
41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.